{"id":"https://openalex.org/W4283366583","doi":"https://doi.org/10.1097/01.hs9.0000850104.80221.19","title":"PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.","display_name":"PB1813: EFFICACY OF AZACITIDINE AND VENETOCLAX IN AML PATIENTS MAY BE LIMITED BY INTERACTION WITH POSACONAZOLE AND LACK OF STANDARDISED TREATMENT PROTOCOL. REAL WORLD DATA FROM 3 MAJOR CENTRES IN SINGAPORE.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283366583","doi":"https://doi.org/10.1097/01.hs9.0000850104.80221.19"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000850104.80221.19","doi":"https://doi.org/10.1097/01.hs9.0000850104.80221.19","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000850104.80221.19","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000850104.80221.19","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017765551","display_name":"Dheepa Christopher","orcid":"https://orcid.org/0000-0002-4864-4628","observed_orcids":["https://orcid.org/0000-0002-4864-4628"]},"institutions":[{"id":"https://openalex.org/I2802408685","display_name":"Tan Tock Seng Hospital","ror":"https://ror.org/032d59j24","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I2802408685"]}],"countries":["SG"],"is_corresponding":true,"raw_author_name":"D. Christopher","raw_affiliation_strings":["Haematology, Tan tock seng hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology, Tan tock seng hospital","institution_ids":["https://openalex.org/I2802408685"]}]},{"author_position":"middle","author":{"id":null,"display_name":"N. A. Abdul Halim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2251586001","display_name":"Singapore General Hospital","ror":"https://ror.org/036j6sg82","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I2251586001"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"N. A. Abdul Halim","raw_affiliation_strings":["Haematology, singapore general hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology, singapore general hospital","institution_ids":["https://openalex.org/I2251586001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074357975","display_name":"Christian Aledia Gallardo","orcid":"https://orcid.org/0000-0001-5048-4259","observed_orcids":["https://orcid.org/0000-0001-5048-4259"]},"institutions":[{"id":"https://openalex.org/I2802408685","display_name":"Tan Tock Seng Hospital","ror":"https://ror.org/032d59j24","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I2802408685"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"C. A. Gallardo","raw_affiliation_strings":["Haematology, Tan tock seng hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology, Tan tock seng hospital","institution_ids":["https://openalex.org/I2802408685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085956130","display_name":"G. H. Lim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2251586001","display_name":"Singapore General Hospital","ror":"https://ror.org/036j6sg82","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I2251586001"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"G. H. Lim","raw_affiliation_strings":["Haematology, singapore general hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology, singapore general hospital","institution_ids":["https://openalex.org/I2251586001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013913233","display_name":"Wei\u2010Ying Jen","orcid":"https://orcid.org/0000-0002-9339-3362","observed_orcids":["https://orcid.org/0000-0002-9339-3362"]},"institutions":[{"id":"https://openalex.org/I4210146690","display_name":"National University Hospital","ror":"https://ror.org/04fp9fm22","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I165932596","https://openalex.org/I4210146690","https://openalex.org/I4210150261"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"W. Y. Jen","raw_affiliation_strings":["Haematology, National university hospital, singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology, National university hospital, singapore, Singapore","institution_ids":["https://openalex.org/I4210146690"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Y. Lin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802408685","display_name":"Tan Tock Seng Hospital","ror":"https://ror.org/032d59j24","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I2802408685"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"C. Y. Lin","raw_affiliation_strings":["Haematology, Tan tock seng hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology, Tan tock seng hospital","institution_ids":["https://openalex.org/I2802408685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086118715","display_name":"E. F. Bingwen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802408685","display_name":"Tan Tock Seng Hospital","ror":"https://ror.org/032d59j24","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I2802408685"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"E. F. Bingwen","raw_affiliation_strings":["Haematology, Tan tock seng hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology, Tan tock seng hospital","institution_ids":["https://openalex.org/I2802408685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006357976","display_name":"Melissa Gaik Ming Ooi","orcid":"https://orcid.org/0000-0002-7392-0655","observed_orcids":["https://orcid.org/0000-0002-7392-0655"]},"institutions":[{"id":"https://openalex.org/I4210146690","display_name":"National University Hospital","ror":"https://ror.org/04fp9fm22","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I165932596","https://openalex.org/I4210146690","https://openalex.org/I4210150261"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"M. Ooi","raw_affiliation_strings":["Haematology, National university hospital, singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology, National university hospital, singapore, Singapore","institution_ids":["https://openalex.org/I4210146690"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039141208","display_name":"Y. L. Chee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146690","display_name":"National University Hospital","ror":"https://ror.org/04fp9fm22","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I165932596","https://openalex.org/I4210146690","https://openalex.org/I4210150261"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Y. L. Chee","raw_affiliation_strings":["Haematology, National university hospital, singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology, National university hospital, singapore, Singapore","institution_ids":["https://openalex.org/I4210146690"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056206781","display_name":"Venkata Sreekanth Sampath","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802408685","display_name":"Tan Tock Seng Hospital","ror":"https://ror.org/032d59j24","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I2802408685"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"V. S. Sampath","raw_affiliation_strings":["Haematology, Tan tock seng hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology, Tan tock seng hospital","institution_ids":["https://openalex.org/I2802408685"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075275096","display_name":"Gee-Chuan Wong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2251586001","display_name":"Singapore General Hospital","ror":"https://ror.org/036j6sg82","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I2251586001"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"G. C. Wong","raw_affiliation_strings":["Haematology, singapore general hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology, singapore general hospital","institution_ids":["https://openalex.org/I2251586001"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5017765551"],"corresponding_institution_ids":["https://openalex.org/I2802408685"],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":"1693","last_page":"1694"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9860000014305115},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/posaconazole","display_name":"posaconazole","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cyp3a4-inhibition","display_name":"CYP3A4 inhibition","score":0.753000020980835},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.6840000152587891},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.8799999952316284},{"id":"https://openalex.org/keywords/newly-diagnosed-aml","display_name":"newly diagnosed AML","score":0.9139999747276306},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.5889999866485596},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.7049999833106995},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.6359999775886536},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8040000200271606},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.6190000176429749},{"id":"https://openalex.org/keywords/singapore-hospitals","display_name":"Singapore hospitals","score":0.3580000102519989},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.8839095234870911},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.8721581101417542},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7819489240646362},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5955580472946167},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.470182329416275},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.425581693649292},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4229852259159088},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4101145267486572},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.33766812086105347},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000850104.80221.19","doi":"https://doi.org/10.1097/01.hs9.0000850104.80221.19","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000850104.80221.19","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9428985","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9428985","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:570302f24d3947329a86ab67a9b83025","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/570302f24d3947329a86ab67a9b83025","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 6, Pp 1693-1694 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000850104.80221.19","doi":"https://doi.org/10.1097/01.hs9.0000850104.80221.19","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000850104.80221.19","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3048827006","https://openalex.org/W4395007466","https://openalex.org/W4386102629","https://openalex.org/W4389664949","https://openalex.org/W4414103075","https://openalex.org/W4285225865","https://openalex.org/W4386282147","https://openalex.org/W4405050710","https://openalex.org/W3215890213","https://openalex.org/W4385667139"],"abstract_inverted_index":{"Background:":[0],"Acute":[1],"myeloid":[2],"leukaemia":[3],"(AML)":[4],"is":[5,44],"a":[6,185,235,518,532],"disease":[7,225,242],"of":[8,52,77,84,111,164,180,210,237,253,324,373,513,517,529],"the":[9,12,45,58,109,199,208,254,265,359,374,422],"elderly,":[10],"with":[11,32,55,64,72,93,121,132,138,234,279,363,421,509],"median":[13,80,300,311,347,380,391,409,423],"age":[14],"at":[15,70,170,198],"diagnosis":[16],"being":[17,427],"68":[18],"years.":[19],"However,":[20,494],"both":[21,98,114],"curative":[22],"and":[23,79,95,102,116,134,140,219,244,284,310,326,369,390,402,441,452,468,479,485,496,511],"palliative":[24],"treatment":[25,48,124,245,524],"options":[26],"for":[27,159,172,221,334,411,425],"elderly":[28],"AML":[29],"are":[30,465],"limited,":[31],"dismal":[33],"five-year":[34],"survival":[35,82,495],"outcomes.":[36],"In":[37,262,472],"Singapore,":[38],"hypomethylating":[39],"agents":[40],"(HMA),":[41],"particularly":[42],"azacitidine,":[43],"most":[46],"used":[47],"in":[49,97,113,142,146,162,295,322,330,469],"this":[50,122],"cohort":[51],"patients.":[53,298],"Consistent":[54],"results":[56],"from":[57,148,249],"phase":[59],"3":[60],"trial,":[61],"our":[62,91,474],"experience":[63,92],"azacitidine":[65,94,139,451,478,530],"only":[66],"showed":[67],"modest":[68],"response":[69,74,267,275,304,384,449,483],"best,":[71],"complete":[73,274],"(CR)":[75],"rate":[76,268],"14.2%":[78],"overall":[81,266],"(OS)":[83],"9.8":[85],"months.":[86,315,395],"Aims:":[87],"Here,":[88],"we":[89],"report":[90],"venetoclax":[96,141,181,480],"newly":[99],"diagnosed":[100],"(ND)":[101],"relapsed/refractory":[103],"(R/R)":[104],"AML.":[105],"We":[106,127],"further":[107],"evaluate":[108],"impact":[110],"heterogeneity":[112],"patients":[115,131,155,336,413,438,489],"clinical":[117],"practices":[118],"on":[119,189,207],"outcome":[120],"novel":[123],"combination.":[125],"Methods:":[126],"included":[128],"100":[129],"consecutive":[130],"ND":[133,263,335,440],"R/R":[135,357,412],"AML,":[136],"treated":[137],"three":[143],"tertiary":[144],"hospitals":[145],"Singapore":[147],"February":[149],"2017":[150],"to":[151,302,382,445,450,460,462,492,507],"March":[152],"2020.":[153],"These":[154],"were":[156,196,247],"deemed":[157],"unfit":[158],"induction":[160],"chemotherapy":[161],"view":[163],"their":[165],"age/comorbidities.":[166],"Azacitidine":[167],"was":[168,182,227,270,293,305,313,320,337,361,385,393,404,414],"dosed":[169],"75mg/m2":[171],"seven":[173],"days":[174],"per":[175],"cycle.":[176],"The":[177,202,299,379,408],"target":[178],"dose":[179,217,520],"400mg":[183],"once":[184],"day.":[186],"For":[187,356],"those":[188],"concomitant":[190],"strong":[191],"CYP3A4":[192],"inhibitor,":[193],"reduced":[194],"doses":[195],"given":[197],"physicians\u2019":[200],"discretion.":[201],"treating":[203],"physicians":[204],"also":[205,536],"decided":[206],"timing":[209],"bone":[211],"marrow":[212],"assessment":[213],"as":[214,216,527,531],"well":[215],"interruptions":[218],"modifications":[220],"toxicities.":[222],"Minimal":[223],"residual":[224],"(MRD)":[226],"assessed":[228],"via":[229],"multiparameter":[230],"flow":[231],"cytometry":[232],"(MFC)":[233],"sensitivity":[236],"10-4.":[238],"Baseline":[239],"demographics":[240],"data,":[241],"characteristics":[243],"details":[246],"obtained":[248],"electronic":[250],"health":[251],"records":[252],"respective":[255],"hospitals,":[256],"after":[257],"obtaining":[258],"IRB":[259],"approval.":[260],"Results:":[261],"patients,":[264,325,358],"(ORR)":[269],"51.9%:":[271],"16.7%":[272],"achieved":[273,321,397],"(CR),":[276],"27.8%":[277],"CR":[278],"incomplete":[280],"count":[281],"recovery":[282],"(CRi),":[283],"7.4%":[285],"morphologic":[286],"leukaemia-free":[287],"state":[288],"(MLFS).":[289],"Amongst":[290],"responders,":[291],"MRD":[292,458],"undetectable":[294,377,457],"13":[296,437],"(46%)":[297],"time":[301,381],"best":[303,383],"1.8":[306,386],"months":[307,339,341,387,416,418],"(1.1-3.5":[308],"months)":[309,389],"DOR":[312,392],"4.8":[314],"Red":[316],"cell":[317,399],"transfusion":[318,328,400,406],"independence":[319,329,401],"38.2%":[323],"platelet":[327,405],"41.8%.":[331],"Median":[332],"OS":[333,348,410,424,487],"8.4":[338],"(4.6":[340],"-NR).":[342],"Responders":[343],"had":[344,376,456],"significantly":[345,428],"longer":[346,429],"than":[349,430],"non-responders":[350,431],"(20":[351],"vs":[352,433],"3.55":[353],"months,":[354,435],"p=<0.001).":[355],"ORR":[360],"48.8%":[362],"11.1%":[364],"achieving":[365],"CR,":[366],"33.3%":[367],"CRi,":[368],"4.4%":[370],"MLFS.":[371],"41.9%":[372],"responders":[375,426],"MRD.":[378],"(1.6-2.1":[388],"4.9":[394],"38.1%":[396,403],"red":[398],"independent.":[407],"8.6":[415],"(4.9":[417],"\u2013":[419],"NR),":[420],"(NR":[432],"4.93":[434],"p=0.006).":[436],"(Five":[439],"eight":[442],"R/R)":[443],"proceeded":[444],"allogeneic":[446],"SCT":[447],"following":[448],"venetoclax.":[453],"Five":[454],"(38.4%)":[455],"prior":[459],"proceeding":[461],"transplant.":[463],"11":[464],"still":[466],"alive":[467],"remission.":[470],"Summary/Conclusion:":[471],"summary,":[473],"analysis":[475],"demonstrated":[476],"that":[477],"show":[481],"high":[482],"rates":[484],"improved":[486],"amongst":[488],"who":[490],"responded":[491],"treatment.":[493],"haematological":[497],"improvement":[498],"may":[499],"be":[500,537],"hampered":[501],"by":[502],"early":[503],"discount":[504],"intuition":[505],"due":[506],"interaction":[508],"posaconazole":[510],"lack":[512],"adherence":[514],"or":[515],"availability":[516],"standardised":[519],"modification":[521],"protocol.":[522],"Alternative":[523],"strategies":[525],"such":[526],"continuation":[528],"single":[533],"agent":[534],"should":[535],"explored.":[538]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2022-06-25T00:00:00"}